Video: Interview With Ovid Therapeutics' Jeremy Levin
This article was originally published in The Pink Sheet Daily
The former Teva CEO now heads up neuroscience-focused Ovid. At BioPharm America, he discussed the trend of execs moving from large pharmas to smaller companies as well as the business strategy for Ovid.
Register for our free email digests: